238 related articles for article (PubMed ID: 29100820)
1. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
Arias-Pulido H; Cimino-Mathews AM; Chaher N; Qualls CR; Joste N; Colpaert C; Marotti JD; Chamberlin MD; Foisey MG; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2021 Dec; 190(3):477-489. PubMed ID: 34542773
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cristofanilli M; Valero V; Buzdar AU; Kau SW; Broglio KR; Gonzalez-Angulo AM; Sneige N; Islam R; Ueno NT; Buchholz TA; Singletary SE; Hortobagyi GN
Cancer; 2007 Oct; 110(7):1436-44. PubMed ID: 17694554
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
[TBL] [Abstract][Full Text] [Related]
6. Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.
Chaher N; Arias-Pulido H; Terki N; Qualls C; Bouzid K; Verschraegen C; Wallace AM; Royce M
Breast Cancer Res Treat; 2012 Jan; 131(2):437-44. PubMed ID: 21360074
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of body mass index in locally advanced breast cancer.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
[TBL] [Abstract][Full Text] [Related]
8. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.
Aguiar MAN; Wanderley CWS; Nobre LMS; Alencar MRM; Saldanha MDPS; Souza AM; Wong DVT; Barros PG; Almeida PRC; Lima-Júnior RCP; Ribeiro RA
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e138-e144. PubMed ID: 28766916
[TBL] [Abstract][Full Text] [Related]
10. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
[TBL] [Abstract][Full Text] [Related]
11. Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory
Monneur A; Goncalves A; Gilabert M; Finetti P; Tarpin C; Zemmour C; Extra JM; Tallet A; Lambaudie E; Jacquemier J; Houvenaeghel G; Boher JM; Viens P; Bertucci F
Oncotarget; 2017 Sep; 8(39):66019-66032. PubMed ID: 29029489
[TBL] [Abstract][Full Text] [Related]
12. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
[TBL] [Abstract][Full Text] [Related]
15. Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
Slaoui M; Zoure AA; Mouh FZ; Bensouda Y; El Mzibri M; Bakri Y; Amrani M
BMC Cancer; 2018 Jul; 18(1):713. PubMed ID: 29976157
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC.
Biswas T; Efird JT; Prasad S; James SE; Walker PR; Zagar TM
Clin Breast Cancer; 2016 Jun; 16(3):212-6. PubMed ID: 26988771
[TBL] [Abstract][Full Text] [Related]
17. Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis.
Attia-Sobol J; Ferrière JP; Curé H; Kwiatkowski F; Achard JL; Verrelle P; Feillel V; De Latour M; Lafaye C; Deloche C
Eur J Cancer; 1993; 29A(8):1081-8. PubMed ID: 8518016
[TBL] [Abstract][Full Text] [Related]
18. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
[TBL] [Abstract][Full Text] [Related]
19. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
